PMID- 19144762 OWN - NLM STAT- MEDLINE DCOM- 20090611 LR - 20211020 IS - 1555-905X (Electronic) IS - 1555-9041 (Print) IS - 1555-9041 (Linking) VI - 4 IP - 2 DP - 2009 Feb TI - Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. PG - 345-53 LID - 10.2215/CJN.02070508 [doi] AB - BACKGROUND AND OBJECTIVES: Thrombotic microangiopathy (TMA) is a known complication of hematopoietic cell transplantation (HCT). The etiology and diagnosis of TMA in this patient population is often difficult because thrombocytopenia, microangiopathic hemolytic anemia, and kidney injury occur frequently in HCT recipients, and are the result of a variety of insults. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: The authors reviewed renal pathology and clinical data from HCT patients to determine the prevalence of TMA and to identify correlative factors for developing TMA in the kidney. Kidney tissue was evaluated from 314 consecutive autopsies on patients who died after their first HCT (received between 1992 and 1999). Renal pathology was classified into three groups: (1) no renal thrombus (65%), (2) TMA (20%), and (3) isolated thrombosis (15%). Logistic regression models estimated the associations between each histologic category and clinical parameters: donor and recipient gender, patient age, human leukocyte antigen (HLA) matching of the donor and recipient, total body irradiation (TBI), acute graft versus host disease (GVHD), acute kidney injury, medications, and viral infections. RESULTS: In a multivariate analysis, TMA correlated with acute GVHD grades II to IV, followed by female recipient/male donor, TBI > 1200 cGy, and adenovirus infection. Grades II to IV acute GVHD and female gender were associated with isolated renal thrombus. CONCLUSIONS: TMA in HCT recipients is associated with acute GVHD grades II to IV, recipient/donor mismatch, TBI > 1200 cGy, and adenovirus infection. FAU - Changsirikulchai, Siribha AU - Changsirikulchai S AD - Department of Medicine, Srinakharinwirot University, Bangkok, Thailand. FAU - Myerson, David AU - Myerson D FAU - Guthrie, Katherine A AU - Guthrie KA FAU - McDonald, George B AU - McDonald GB FAU - Alpers, Charles E AU - Alpers CE FAU - Hingorani, Sangeeta R AU - Hingorani SR LA - eng GR - CA18029/CA/NCI NIH HHS/United States GR - K23 DK063038/DK/NIDDK NIH HHS/United States GR - P01 CA018029/CA/NCI NIH HHS/United States GR - K23 DK63038/DK/NIDDK NIH HHS/United States GR - HL3644/HL/NHLBI NIH HHS/United States GR - CA5704/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20090114 PL - United States TA - Clin J Am Soc Nephrol JT - Clinical journal of the American Society of Nephrology : CJASN JID - 101271570 SB - IM MH - Adenoviridae Infections/complications MH - Adolescent MH - Adult MH - Aged MH - Autopsy MH - Child MH - Child, Preschool MH - Female MH - Graft vs Host Disease/*complications/mortality/pathology MH - Hematopoietic Stem Cell Transplantation/*adverse effects/mortality MH - Humans MH - Infant MH - Kidney/pathology MH - Kidney Diseases/*etiology/mortality/pathology MH - Logistic Models MH - Male MH - Middle Aged MH - Odds Ratio MH - Prevalence MH - Radiation Dosage MH - Risk Assessment MH - Risk Factors MH - Severity of Illness Index MH - Sex Factors MH - Thrombocytopenia/*etiology/mortality/pathology MH - Thrombosis/*etiology/mortality/pathology MH - Young Adult PMC - PMC2637592 EDAT- 2009/01/16 09:00 MHDA- 2009/06/12 09:00 PMCR- 2010/02/01 CRDT- 2009/01/16 09:00 PHST- 2009/01/16 09:00 [entrez] PHST- 2009/01/16 09:00 [pubmed] PHST- 2009/06/12 09:00 [medline] PHST- 2010/02/01 00:00 [pmc-release] AID - CJN.02070508 [pii] AID - 0508 [pii] AID - 10.2215/CJN.02070508 [doi] PST - ppublish SO - Clin J Am Soc Nephrol. 2009 Feb;4(2):345-53. doi: 10.2215/CJN.02070508. Epub 2009 Jan 14.